Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms (MPN).
暂无分享，去创建一个
E. Clappier | W. Vainchenker | E. Raffoux | C. Dosquet | N. Gauthier | J. Zini | N. Parquet | S. Giraudier | J. Kiladjian | B. Cassinat | D. Réa | E. Verger | Blandine Roux | L. Benajiba | N. Maslah | Lin-Pierre Zhao | J. Soret-Dulphy | Clemence Marcault | Rafael Daltro De Oliveira | Clémence Marcault | C. Marcault | R. Daltro De Oliveira | R. Daltro de Oliveira